Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02381314
Title Safety Study of MGA271 in Combination With Ipilimumab in Refractory Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors MacroGenics
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
UCLA Hematology-Oncology Clinic Los Angeles California 90095 United States Details
Yale University New Haven Connecticut 06520 United States Details
Mount Sinai Medical Center Miami Beach Florida 33140 United States Details
University of Chicago Chicago Illinois 60637 United States Details
Indiana University Simon Cancer Center Indianapolis Indiana 46202 United States Details
Washington University School of Medicine in St. Louis Saint Louis Missouri 63110 United States Details
Columbia University Medical Center New York New York 10032 United States Details
Providence Portland Medical Center Portland Oregon 97213 United States Details
Center for Oncology and Blood Disorders Houston Texas 77030 United States Details
University of Wisconsin Madison Wisconsin 53792 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field